Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Income Operating Income Growth	-9.1	-9.22	-8.31	-11.78	-6.83	-3.61
Net Income Net Income Growth	-7.98	-8.48	-8.2	-11.73	-6.83	-38.46
Earnings Per Share EPS Growth	-0.19	-0.25	-0.32	-0.47	-0.29	-2.83
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	9.04	11.63	3.09	11.25	14.55	19.99
Total Debt Total Debt Growth	0	0	0	0	0	0
Net Cash (Debt) Net Cash Growth	9.04	11.63	3.09	11.25	14.55	19.99
Net Cash Growth	-39.72%	275.80%	-72.49%	-22.69%	-27.21%	607.78%
Net Cash Per Share Net Cash Per Share Growth	0.22	0.34	0.12	0.45	0.62	1.47

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	-5.84	-6.35	-8.09	-9.68	-5.44	-4.87
Free Cash Flow Free Cash Flow Growth	-5.84	-6.35	-8.09	-9.68	-5.44	-4.87
Free Cash Flow Growth	-	-	-	-	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error